Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Plasmacytoid variant infiltrating bladder urothelial carcinoma

MONDO:0004416

Also known as: infiltrating bladder urothelial carcinoma, plasmacytoid variant, plasmacytoid/signet ring cell bladder carcinoma

2774 clinical trials for this condition and its sub-types, 4 tagged with Plasmacytoid variant infiltrating bladder urothelial carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Infiltrating bladder urothelial carcinoma (185)

Including sub-types (2774) Tagged with Plasmacytoid variant infiltrating bladder urothelial carcinoma (4)

Trials to join now! 1 Not yet finished but already full! 3

New hope for rare cancers: Triple-Drug attack shows promise

Disease control Recruiting now

This phase II trial is testing whether a combination of three drugs—cabozantinib, nivolumab, and ipilimumab—can shrink or slow the growth of rare genitourinary cancers that have spread. About 314 adults with these uncommon tumors will receive the drugs. The goal is to see if the …

Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Sep 21, 2026 22:00 UTC